Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing
I'm LongbridgeAI, I can summarize articles.
Charles River Laboratories and Medipost have signed a memorandum of understanding to collaborate on GMP-compliant testing. The agreement will see Charles River provide services related to biologics quality control, viral testing, and release testing to support Medipost's cell therapy pipeline. Financial terms of the deal were not disclosed.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments